| Xtandi 80 mg film-coated tablets EU/1/13/846/003 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |
| Xtex 250 mg /5 ml oral solution PA0074/071/001 |
Carbocisteine |
Rowa Pharmaceuticals Limited, |
Marketed |
| Xultophy 100 units/mL + 3.6 mg/mL solution for injection. EU/1/14/947/001-004 |
Insulin degludec, Liraglutide |
Novo Nordisk A/S |
— |
| Xydalba EU/1/14/986/001 |
Dalbavancin hcl |
AbbVie Deutschland GmbH & Co. KG |
— |
| Xyrem 500 mg/mL oral solution EU/1/05/312/001 |
Sodium Oxybate |
UCB Pharma S.A. |
— |
| Yargesa 100 mg hard capsules EU/1/17/1176/001 |
Miglustat |
Piramal Critical Care B.V. |
— |
| Yaxwer 120 mg solution for injection EU/1/25/1934/001-003 |
Denosumab |
Gedeon Richter Plc |
— |
| Yellox 0.9 mg/ml eye drops solution EU/1/11/692/001 |
Bromfenac sodium sesquihydrate |
Bausch Health Ireland Limited |
— |
| Yentreve EU/1/04/280/1-6 |
Duloxetine hydrochloride |
Eli Lilly Nederland B.V. |
— |
| Yentreve 20 mg hard gastro-resistant capsules EU/1/04/280/001 |
Duloxetine hydrochloride |
Eli Lilly Nederland B.V. |
— |
| YERVOY 5 mg/ml concentrate for solution for infusion EU/1/11/698/001-002 |
Ipilimumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Yesafili 40 mg/mL solution for injection in pre-filled syringe. EU/1/23/1751/001-002 |
Aflibercept |
Biosimilar Collaborations Ireland Limited |
— |
| Yescarta 0.4 – 2 × 108 cells dispersion for infusion EU/1/18/1299/001 |
AXICABTAGENE CILOLEUCEL |
Kite Pharma EU B.V. |
— |
| Yesintek 130 mg Concentrate for solution for infusion EU/1/24/1892/004 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection EU/1/24/1892/002 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection Subcutaneous use EU/1/24/1892/001 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 90 mg Solution for injection EU/1/24/1892/003 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yeytuo 300 mg film-coated tablets EU/1/25/1976/001 |
Lenacapavir sodium |
Gilead Sciences Ireland Unlimited Company |
— |
| Yeytuo 464 mg solution for injection EU/1/25/1976/002 |
Lenacapavir sodium |
Gilead Sciences Ireland Unlimited Company |
— |
| Yondelis 0.25 mg Powder for concentrate for solution for infusion EU/1/07/417/1 |
Trabectedin |
Pharma Mar S.A. |
— |
| Yondelis 1 mg Powder for concentrate for solution for infusion EU/1/07/417/2 |
Trabectedin |
Pharma Mar S.A. |
— |
| Yorvipath 168 micrograms/0.56 mL solution for injection in pre-filled pen EU/1/23/1766/001 |
Palopegteriparatide, Teriparatide |
Ascendis Pharma Bone Diseases A/S |
— |
| Yorvipath 294 micrograms/0.98 mL solution for injection in pre-filled pen EU/1/23/1766/002 |
Palopegteriparatide, Teriparatide |
Ascendis Pharma Bone Diseases A/S |
— |
| Yorvipath 420 micrograms/1.4 mL solution for injection in pre-filled pen EU/1/23/1766/003 |
Palopegteriparatide, Teriparatide |
Ascendis Pharma Bone Diseases A/S |
— |
| Yselty 100 mg film-coated tablets EU/1/21/1606/001 |
Linzagolix Choline |
Theramex Ireland Limited |
— |
| Yselty 200 mg film-coated tablets EU/1/21/1606/002 |
Linzagolix Choline |
Theramex Ireland Limited |
— |
| Yttriga EU/1/05/322/001 |
Yttrium (90 y) |
Eckert & Ziegler Radiopharma GmbH |
— |
| Yuflyma EU/1/20/1513/001-012 |
Adalimumab |
Celltrion Healthcare Hungary Kft. |
— |
| Yuflyma EU/1/20/1513/013-016 |
Adalimumab |
Celltrion Healthcare Hungary Kft. |
— |
| Yuflyma 20 mg solution for injection in pre-filled syringe EU/1/20/1513/017 |
Adalimumab |
Celltrion Healthcare Hungary Kft. |
— |
| Yuvanci 10 mg/20 mg film-coated tablets EU/1/24/1859/001 |
Macitentan, Tadalafil |
Janssen Pharmaceutica NV |
— |
| Yuvanci 10 mg/40 mg film-coated tablets EU/1/24/1859/002 |
Macitentan, Tadalafil |
Janssen Pharmaceutica NV |
— |
| Zacin 0.025% w/w Cream PA23369/005/001 |
Capsaicin |
Ennogen Healthcare (Europe) Limited |
Marketed |
| ZADENVI 60 mg solution for injection in pre-filled syringe EU/1/25/1937/001 |
Denosumab |
Zentiva k.s. |
— |
| Zalasta 10 mg Orodispersible tablet EU/1/07/415/42-46 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 10 mg Tablet EU/1/07/415/16-21 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 15 mg Orodispersible tablet EU/1/07/415/47-51 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 15 mg Tablet EU/1/07/415/22-26 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 2.5 mg Tablet EU/1/07/415/1-5 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 20 mg Orodispersible tablet EU/1/07/415/52-56 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 20 mg Tablet EU/1/07/415/27-31 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 5 mg Orodispersible tablet EU/1/07/415/32-36 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 5 mg Tablet EU/1/07/415/006 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 7.5 mg Orodispersible tablet EU/1/07/415/37-41 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 7.5 mg Tablet EU/1/07/415/11-15 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| ZALTRAP 25 mg/ml concentrate for solution for infusion EU/1/12/814/001-003 |
Aflibercept |
Sanofi Winthrop Industrie |
— |
| Zanidip 10 mg film-coated tablets PA0812/001/001 |
Lercanidipine hydrochloride |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |
| ZANIDIP 10 mg Film-coated Tablets PPA23080/034/001 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| ZANIDIP 20 mg Film-coated Tablets PPA23080/034/002 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Zanidip 20mg film-coated tablets PA0812/001/002 |
Lercanidipine hydrochloride |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |